Search alternatives:
deceased decrease » related decrease (Expand search)
costs decrease » loss decrease (Expand search), not decrease (Expand search), cells decrease (Expand search)
decrease after » disease after (Expand search)
disease costs » disease cost (Expand search), disease cross (Expand search), disease cases (Expand search)
decrease with » decreases with (Expand search), increase with (Expand search), decrease in (Expand search)
with deceased » with decreased (Expand search), with increased (Expand search), with disease (Expand search)
deceased decrease » related decrease (Expand search)
costs decrease » loss decrease (Expand search), not decrease (Expand search), cells decrease (Expand search)
decrease after » disease after (Expand search)
disease costs » disease cost (Expand search), disease cross (Expand search), disease cases (Expand search)
decrease with » decreases with (Expand search), increase with (Expand search), decrease in (Expand search)
with deceased » with decreased (Expand search), with increased (Expand search), with disease (Expand search)
1
3
4
“...ABSTRACT For patients with end stage renal disease, kidney transplant offers significant survival...”
Access document
Access document
Report
5
“... incorporates the natural history, costs and quality of life of all the tobacco-related adult-specific diseases...”
Access document
Access document
Article
6
“.... To describe, as disease progresses, how it is like to care for a PwD in a familial context and the costs...”
Access document
Access document
7
8
10
11
12
13
14
“...Objective: to evaluate the costs of hospitalizations for ambulatory care sensitive conditions...”
Access document
Access document
Article
15
“... of hospitalization decrease with increasing age. 70.6% of total expenditures (R$ 71,480,950.14) were for circulatory...”
Access document
Access document
Article
16
17
“...Parkinson's disease (PD) is a common disorder that causes a marked decrease in the quality of life...”
Access document
Access document
Article
18
19
20
“... to increase targeted driven therapy and decrease adverse events and their costs....”
Access document
Access document
Article